(Q50642548)

17 March 2018

title

Some aspects of the cost of schizophrenia in France. (English)

1 reference

17 March 2018

0 references

F Rouillon

1

1 reference

17 March 2018

M Toumi

2

1 reference

17 March 2018

G Y Dansette

3

1 reference

17 March 2018

J Benyaya

4

1 reference

17 March 2018

P Auquier

5

1 reference

17 March 2018

publication date

1 June 1997

1 reference

17 March 2018

published in

PharmacoEconomics

1 reference

17 March 2018

volume

11

1 reference

17 March 2018

issue

6

1 reference

17 March 2018

page(s)

578-594

1 reference

17 March 2018

https://scigraph.springernature.com/pub.10.2165/00019053-199711060-00006

exact match

0 references

cites work

Gender and the course of schizophrenia: differences in treated outcomes.

1 reference

12 December 2020

Evaluating effectiveness and cost of community care for schizophrenic patients

1 reference

12 December 2020

The cost of schizophrenia

1 reference

12 December 2020

The economic costs of schizophrenia. Implications for public policy

1 reference

12 December 2020

The costs of schizophrenia. Assessing the burden.

1 reference

12 December 2020

Effectiveness and cost of community care for schizophrenic patients.

1 reference

12 December 2020

Depot antipsychotic drugs. Place in therapy

1 reference

12 December 2020

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

1 reference

12 December 2020

Why do schizophrenic patients refuse to take their drugs?

1 reference

12 December 2020

Mortality in psychiatric hospitals in Norway 1950?74

1 reference

12 December 2020

Compliance, quality assurance and standards for relapse prevention in schizophrenia.

1 reference

12 December 2020

Prevalence studies in schizophrenia

1 reference

12 December 2020

Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.

1 reference

12 December 2020

Compliance in the long-term treatment of schizophrenia

1 reference

12 December 2020

Overview: maintenance therapy in psychiatry: I. Schizophrenia

1 reference

12 December 2020

A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic

1 reference

12 December 2020

Schizophrenia in a North Swedish geographical isolate, 1900-1977. Epidemiology, genetics and biochemistry

1 reference

12 December 2020

Symptom profiles and homelessness in schizophrenia

1 reference

12 December 2020

Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders.

1 reference

12 December 2020

Poverty and the course of schizophrenia: implications for research and policy.

1 reference

12 December 2020

Epidemiologic survey of psychiatric disorders in specialized consultation

1 reference

12 December 2020

[Cost and benefits in social psychiatry: should one economize or develop?]

1 reference

12 December 2020

Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites

1 reference

12 December 2020

Schizophrenia: a life-shortening disease.

1 reference

12 December 2020

Violence and psychosis. II--Effect of psychiatric diagnosis on conviction and sentencing of offenders

1 reference

12 December 2020

Economics and schizophrenia: the real cost.

1 reference

12 December 2020

Epidemiology of schizophrenia: a European perspective

1 reference

12 December 2020

Sex difference in age at onset of schizophrenia

1 reference

12 December 2020

[Mortality and cause of death in schizophrenia. Review of the literature]

1 reference

12 December 2020

10.2165/00019053-199711060-00006

Identifiers

DOI

1 reference

17 March 2018

Dimensions Publication ID

1010451127

0 references

Fatcat ID

release_syehu2s6lzgvxjfrxo6kbkcnyi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/syehu2s6lzgvxjfrxo6kbkcnyi

24 November 2022

mapped directly with Wikidata item

PubMed ID

10168096

1 reference

17 March 2018